Sibel Health
Sibel Health offers advanced wearable solutions for clinical trials, clinical care, sleep diagnostics, and remote patient monitoring, with a focus on neonatal, maternal, and adult care.
Services
Sibel Health offers a range of solutions tailored for clinical trials and research, clinical care, sleep diagnostics, and remote patient monitoring. Their advanced technology supports neonatal care, maternal health, adult care, hospital-at-home solutions, and global health. With over 5,000 systems deployed in more than 20 countries, Sibel Health has monitored over 15,000 patients worldwide. Their services leverage wireless sensors for proactive health monitoring and intervention.
Products
Sibel Health provides a suite of wearable devices, including the ANNE® Chest, ANNE® Limb, and ADAM sensors. The ANNE® Chest sensor tracks heart rate, respiratory rate, temperature, body position, and activity, while the ANNE® Limb sensor measures SpO2 pulse rate, perfusion index, and skin temperature. The ADAM sensor captures detailed physiological data and features a BLE radio, electronics, and a rechargeable battery. ANNE® Sleep offers clinical-grade sleep diagnostics with wireless sensors and a smart charger. Additionally, the ANNE® One is an FDA-cleared wireless monitoring solution ideal for labor triage and continuous maternal health monitoring.
Global Health Initiatives
Sibel Health is committed to advancing global health through the deployment of wireless sensors for proactive monitoring and intervention. The company has received a $17.5 million grant from the Bill & Melinda Gates Foundation aimed at improving maternal health monitoring in low-and-middle-income countries. Their technologies support neonatal and maternal care, aligned with efforts to enhance health outcomes on a global scale.
Funding and Achievements
Sibel Health has successfully raised $33 million in Series B funding. The company has achieved significant milestones, including the announcement of its 4th FDA clearance for continuous wearable vital signs monitoring with ANNE® One. Their technology has been validated in peer-reviewed publications and is trusted in various clinical settings.
Headquarters and Offices
Sibel Health is headquartered in Chicago, IL, and maintains an additional office in Seoul, South Korea. This strategic geographic presence enables the company to support its global operations and collaborate effectively with international partners and clients.